We then conducted experiments to define the role of SIRPγ in the growth of organoids from NSCLC patient–derived tumors and found that SIRPγ or YAP overexpression promoted cancer organoid growth, while SIRPγ or YAP knockdown reduced it (Figure 3, J–L). The gene discussed is YAP1; the disease is cancer.